Twin SUBLIVAC® Grasses Clinical Efficacy Study

NCT00422149 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal
Conjunctivitis, Allergic

Interventions

DRUG: SUBLIVAC® Grasses/Placebo treatment
DRUG: SUBLIVAC® Grasses treatment
DRUG: Placebo treatment

Sponsor

HAL Allergy